102 related articles for article (PubMed ID: 7459806)
21. Attributes and survival patterns of multiple primary cutaneous malignant melanoma.
Gupta BK; Piedmonte MR; Karakousis CP
Cancer; 1991 Apr; 67(7):1984-9. PubMed ID: 2004315
[TBL] [Abstract][Full Text] [Related]
22. Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials.
Joosse A; Collette S; Suciu S; Nijsten T; Lejeune F; Kleeberg UR; Coebergh JW; Eggermont AM; de Vries E
J Clin Oncol; 2012 Jun; 30(18):2240-7. PubMed ID: 22547594
[TBL] [Abstract][Full Text] [Related]
23. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous malignant melanoma in south-east Scotland.
Pondes S; Hunter JA; White H; McIntyre MA; Prescott RJ
Q J Med; 1981; 50(197):103-21. PubMed ID: 7267966
[TBL] [Abstract][Full Text] [Related]
25. Conditional survival of malignant melanoma in The Netherlands: 1994-2008.
van der Leest RJ; van Steenbergen LN; Hollestein LM; de Vries E; Nijsten T; van Akkooi AC; Janssen-Heijnen ML; Coebergh JW
Eur J Cancer; 2014 Feb; 50(3):602-10. PubMed ID: 24262585
[TBL] [Abstract][Full Text] [Related]
26. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
[TBL] [Abstract][Full Text] [Related]
27. Survival rates of patients with malignant melanoma of the skin.
Pakkanen M
Ann Chir Gynaecol; 1977; 66(1):31-5. PubMed ID: 848849
[TBL] [Abstract][Full Text] [Related]
28. Malignant melanoma in Chile: an unusual distribution of primary sites in men from low socioeconomic strata.
Zemelman V; Roa J; Tagle SR; Valenzuela CY
Clin Exp Dermatol; 2006 May; 31(3):335-8. PubMed ID: 16681570
[TBL] [Abstract][Full Text] [Related]
29. Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I.
Johnson OK; Emrich LJ; Karakousis CP; Rao U; Greco WR
Cancer; 1985 Mar; 55(5):1107-17. PubMed ID: 3967194
[TBL] [Abstract][Full Text] [Related]
30. Prognosis in malignant melanoma of the skin. Significance of stage of disease, anatomical site, sex, age and period of diagnosis.
Magnus K
Cancer; 1977 Jul; 40(1):389-97. PubMed ID: 880566
[TBL] [Abstract][Full Text] [Related]
31. Impact of socioeconomic status and district of residence on cutaneous malignant melanoma prognosis: a survival study on incident cases between 1991 and 2011 in the province of Ferrara, northern Italy.
Borghi A; Corazza M; Virgili A; Lambertini AG; Caranci N; Pacelli B; Carcoforo P; Ferretti S
Melanoma Res; 2017 Dec; 27(6):619-624. PubMed ID: 28723726
[TBL] [Abstract][Full Text] [Related]
32. Sex differences in presentation of cutaneous malignant melanoma and in survival from stage I disease.
O'Doherty CJ; Prescott RJ; White H; McIntyre M; Hunter JA
Cancer; 1986 Aug; 58(3):788-92. PubMed ID: 3731029
[TBL] [Abstract][Full Text] [Related]
33. Clinical and pathological features of cutaneous malignant melanoma: a retrospective analysis of 124 Japanese patients.
Kuno Y; Ishihara K; Yamazaki N; Mukai K
Jpn J Clin Oncol; 1996 Jun; 26(3):144-51. PubMed ID: 8656554
[TBL] [Abstract][Full Text] [Related]
34. Adverse effect of pregnancy on melanoma: a reappraisal.
Shiu MH; Schottenfeld D; Maclean B; Fortner JG
Cancer; 1976 Jan; 37(1):181-7. PubMed ID: 1247953
[TBL] [Abstract][Full Text] [Related]
35. Improving survival of melanoma patients in Europe since 1978. EUROCARE Working Group.
Smith JA; Whatley PM; Redburn JC
Eur J Cancer; 1998 Dec; 34(14 Spec No):2197-203. PubMed ID: 10070287
[TBL] [Abstract][Full Text] [Related]
36. Malignant melanoma: some aspects of pathology and prognosis.
Ironside P; Pitt TT; Rank BK
Aust N Z J Surg; 1977 Feb; 47(1):70-5. PubMed ID: 266917
[TBL] [Abstract][Full Text] [Related]
37. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
Downing A; Yu XQ; Newton-Bishop J; Forman D
Int J Cancer; 2008 Aug; 123(4):861-6. PubMed ID: 18500743
[TBL] [Abstract][Full Text] [Related]
38. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
[TBL] [Abstract][Full Text] [Related]
39. Survival advantage of women in localized melanoma mainly relies on clinical-pathological differences by sex. A retrospective study of 1,607 patients in Valencia, Spain.
Kindem S; Garcías-Ladaria J; Requena C; Guillén C; Oliver V; Nagore E
Eur J Dermatol; 2015; 25(3):247-54. PubMed ID: 25961331
[TBL] [Abstract][Full Text] [Related]
40. A retrosepctive histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 6. The relation of dermal solar elastosis to sex, age and survival of the patient and to localization, histological type and level of invasion of the tumour.
Larsen TE; Grude TH
Acta Pathol Microbiol Scand A; 1979 Sep; 87A(5):361-6. PubMed ID: 525350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
